License-Out
License Agreement has been entered into with Arvinas Operations, Inc.
We executed a non-exclusive license agreement for internal research with Arvinas Operations, Inc. (Connecticut, U.S.A.) to access iPS cell r...
results 51 - 60 of 228
License-Out
License Agreement has been entered into with Anatomic Incorporated
We have executed a non-exclusive license agreement with Anatomic Incorporated (Minneapolis, MN, U.S.A.). With this license, Anatomic will be...
License-Out
License Agreement has been entered into with Cytochroma Limited
We have executed a non-exclusive license agreement with Cytochroma Limited (Edinburgh, U.K.) for allowing them to sell iPS cell-derived cell...
Other
Our Office Closed June 18
Our office will be closed on Thursday 18th June 2020 for the Foundation Day of Kyoto University where we are located.Please understand that ...
License-Out
License Agreement Has Been Entered into with Rege Nephro Co.,Ltd.
We have executed a worldwide license agreement with Rege Nephro Co.,Ltd. (Kyoto, Japan) for development and provision of regenerative medici...
License-In
Summary of 6 newly published patent applications are added to "Patent Portfolio"
We released the summary of 6 newly published patent applications from our "Patent Portfolio" as follows. AJ195 PROPHYLACTIC, THERAPEUTIC, OR...
Other
Updated the "Related Patent Info."
New patent information relates to iPS cell technologies for the month of March 2020 has been updated. Please see Related Patent Info. for mo...
Other
Our Office Closed April. 30 - May 6
Our office will be closed from Friday 30th April to Wednesday to 6th May 2020 for temporary closure and Japanese National holidays. Please u...
Other
Updated the "Related Patent Info."
New patent information relates to iPS cell technologies for the month of February 2020 has been updated. Please see Related Patent Info. for...
License-In
Summary of 3 newly published patent applications are added to "Patent Portfolio"
We released the summary of 3 newly published patent applications from our "Patent Portfolio" as follows. AJ166 CARDIOMYOCYTE PROPAGATION PRO...
